ChromaDex Trims Loss, Adds Nestle As Niagen Customer ChromaDex, Inc. on 2 November reported net sales off 1% to $17.1m, including $14.6m revenues from its Tru Niagen nicotinamide riboside supplement
A ChromaDex Corp. executive provided too much information for the Council for Responsible Nutrition’s liking on the firm’s litigation against Elysium Health Inc. during the trade group’s recent webi
Nestle Health Science SA has entered into a strategic collaboration with Netherlands-based Caelus Health to develop microbiome-based food supplements for the prevention and early treatment of cardio-
US-based ChromaDex Corp. said it had completed a “critical step” in its journey to launch its Niagen anti-aging dietary supplement in Europe after securing a positive recommendation from the EU’s ch